Fitzgerald Kevin Joseph bought ALNY
February 23, 2026 · Form 4 insider transaction
Fitzgerald Kevin Joseph bought 158 shares of Alnylam Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
158
Price
$0.00
Total value
N/A
InsiderFitzgerald Kevin Joseph
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 23, 2026
Filing dateFebruary 25, 2026
Shares owned after21,422
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 23, 2026, the People, Culture, and Compensation Committee of the issuer approved the issuance of shares of Company common stock having an aggregate value of USD $100,000 to each employee who completes 20 consecutive years of employment. The shares issued and reported here on Form 4, net of the minimum statutory tax liability, were issued to the reporting person in recognition of 20 years of continuous employment on December 5, 2025.